JPMorgan Chase & Co. Buys 129,854 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

JPMorgan Chase & Co. boosted its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) by 131.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 228,652 shares of the company’s stock after buying an additional 129,854 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.59% of Viemed Healthcare worth $1,834,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of VMD. R Squared Ltd bought a new stake in Viemed Healthcare during the fourth quarter worth $41,000. EntryPoint Capital LLC bought a new stake in shares of Viemed Healthcare during the 4th quarter worth $92,000. Prudential Financial Inc. purchased a new stake in Viemed Healthcare during the fourth quarter worth about $93,000. Bailard Inc. bought a new stake in Viemed Healthcare in the fourth quarter worth about $255,000. Finally, SG Americas Securities LLC boosted its stake in Viemed Healthcare by 193.1% in the fourth quarter. SG Americas Securities LLC now owns 35,579 shares of the company’s stock valued at $285,000 after acquiring an additional 23,442 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Trading Up 2.2 %

Shares of VMD stock opened at $6.98 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The firm has a market cap of $275.86 million, a P/E ratio of 25.85 and a beta of 1.64. The company has a 50 day moving average of $7.26 and a 200-day moving average of $8.08. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $9.81.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.